Healthcare Sector Review: Winning and Losing Stocks on Oct 21st

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Sucampo Pharmaceuticals (NASDAQ:SCMP): The shares closed at $4.49, up $0.45, or 11.14%, on the day. Its market capitalization is $188.05 million. About the company: Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.
  • Nektar Therapeutics (NASDAQ:NKTR): The shares closed at $5.00, up $0.5, or 11.11%, on the day. Its market capitalization is $572.09 million. About the company: Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company’s product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.
  • Exelixis, Inc. (NASDAQ:EXEL): The shares closed at $5.99, up $0.52, or 9.51%, on the day. Its market capitalization is $772.56 million. About the company: Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
  • Accuray Incorporated (NASDAQ:ARAY): The shares closed at $3.96, up $0.34, or 9.39%, on the day. Its market capitalization is $278.67 million. About the company: Accuray Inc. has developed an intelligent robotic radiosurgery system designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.
  • Vision-Sciences, Inc. (NASDAQ:VSCI): The shares closed at $2.28, up $0.18, or 8.57%, on the day. Its market capitalization is $101.39 million. About the company: Vision-Sciences, Inc. develops, manufactures, and markets products for endoscopy which have infection control advantages over conventional flexible endoscopes. The Company’s systems consist of the EndoSheath sterile disposable sheath and a reusable flexible endoscope. Vision-Sciences’ products are designed for use in fields such as gastroenterology, otolaryngology, and pulmonary medicine.

Losers (% price change)

  • Pharmasset, Inc. (NASDAQ:VRUS): The shares closed at $72.54, down $6.86, or 8.64%, on the day. Its market capitalization is $5.47 billion. About the company: Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
  • Hansen Medical, Inc. (NASDAQ:HNSN): The shares closed at $3.06, down $0.11, or 3.47%, on the day. Its market capitalization is $167.94 million. About the company: Hansen Medical, Inc. develops and manufactures medical robotics designed for positioning, manipulation and control of catheters and catheter-based technologies.
  • AtriCure Inc. (NASDAQ:ATRC): The shares closed at $11.63, down $0.39, or 3.24%, on the day. Its market capitalization is $189.16 million. About the company: AtriCure, Inc. develops, manufactures, and sells surgical devices designed to create precise lesions in soft tissues. The Company’s bipolar ablation system is used by cardiothoracic surgeons as a standard treatment alternative to create lesions in heart tissue to block the abnormal electrical impulses that cause atrial fibrillation.
  • Albany Molecular Research (NASDAQ:AMRI): The shares closed at $3.39, down $0.1, or 2.87%, on the day. Its market capitalization is $103.93 million. About the company: Albany Molecular Research, Inc., an integrated chemistry outsourcing company, offers a variety of chemistry research and development services. The Company provides its services to pharmaceutical and biotechnology companies involved in drug discovery and development. Albany offers medicinal chemistry, chemical development, analytical chemistry services, and small-scale manufacturing.
  • (): The shares closed at $54.38, down $1.51, or 2.69%, on the day. Its market capitalization is $134.18 million.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>